Differential impact of cisplatin dose intensity on human papillomavirus (HPV)-related (+) and HPV-unrelated (-) locoregionally advanced head and neck squamous cell carcinoma (LAHNSCC)
2015-01-01 Spreafico, A; Huang, Sh; Xu, W; Granata, R; Liu, Cs; Waldron, Jn; Chen, E; Ringash, J; Bayley, A; Chan, Kk; Hope, Aj; Razak, Ara; Perez-Ordonez, B; Weinreb, I; Bossi, P; Orlandi, E; Licitra, Lf; O'Sullivan, B; Siu, Ll; Kim, Jhj
Targeting the EGFR and immune pathways in squamous cell carcinoma of the head and neck (SCCHN): Forging a new alliance
2019-01-01 Saba, N. F.; Chen, Z. G.; Haigentz, M.; Bossi, P.; Rinaldo, A.; Rodrigo, J. P.; Makitie, A. A.; Takes, R. P.; Strojan, P.; Vermorken, J. B.; Ferlito, A.
Comment on 'Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base'
2015-01-01 Bossi, P; Orlandi, E; Licitra, L
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
2017-01-01 Bossi, P.; Miceli, R.; Locati, L. D.; Ferrari, D.; Vecchio, S.; Moretti, G.; Denaro, N.; Caponigro, F.; Airoldi, M.; Moro, C.; Vaccher, E.; Sponghini, A.; Caldara, A.; Rinaldi, G.; Ferrau, F.; Nole, F.; Lo Vullo, S.; Tettamanzi, F.; Hollander, L.; Licitra, L.
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis
2021-01-01 Milione, M.; Maisonneuve, P.; Grillo, F.; Mangogna, A.; Centonze, G.; Prinzi, N.; Pusceddu, S.; Garzone, G.; Cattaneo, L.; Busico, A.; Bossi, P.; Spaggiari, P.; Pellegrinelli, A.; Del Gobbo, A.; Ferrero, S.; Kankava, K.; Pruneri, G.; Rolli, L.; Roca, E.; Bercich, L.; Tironi, A.; Benvenuti, M. R.; Gallazzi, M. S.; Romano, R.; Berruti, A.; Pastorino, U.; Capella, C.
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
2016-01-01 Locati, Ld; Perrone, F; Cortelazzi, B; Bergamini, C; Bossi, P; Civelli, E; Morosi, C; Lo Vullo, S; Imbimbo, M; Quattrone, P; Dagrada, Gp; Granata, R; Resteghini, C; Mirabile, A; Alfieri, S; Orlandi, E; Mariani, L; Saibene, G; Pilotti, S; Licitra, L
Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature
2019-01-01 Bossi, P.; Alfieri, S.; Strojan, P.; Takes, R. P.; Lopez, F.; Makitie, A.; Saba, N. F.; Rodrigo, J. P.; Bradford, C.; Suarez, C.; Zafereo, M.; Forastiere, A. A.; Vermorken, J. B.; Quer, M.; Sanabria, A.; Simo, R.; de Bree, R.; Rinaldo, A.; Ferlito, A.
Vitamin D supplementation and cancer mortality: Narrative review of observational studies and clinical trials
2021-01-01 Gnagnarella, P.; Muzio, V.; Caini, S.; Raimondi, S.; Martinoli, C.; Chiocca, S.; Miccolo, C.; Bossi, P.; Cortinovis, D.; Chiaradonna, F.; Palorini, R.; Facciotti, F.; Bellerba, F.; Canova, S.; Gandini, S.
Corrigendum to "Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma" [Eur J Canc 157 (2021) 250-258]
2022-01-01 Baggi, Alice; Quaglino, Pietro; Rubatto, Marco; Depenni, Roberta; Guida, Michele; Ascierto, Paolo Antonio; Trojaniello, Claudia; Queirolo, Paola; Saponara, Maristella; Peris, Ketty; Spagnolo, Francesco; Bianchi, Luca; De Galitiis, Federica; Potenza, Maria Concetta; Proietti, Ilaria; Marconcini, Riccardo; Botticelli, Andrea; Barbieri, Vito; Licitra, Lisa; Alfieri, Salvatore; Ficorella, Corrado; Cortellini, Alessio; Fargnoli, Maria Concetta; Troiani, Teresa; Tondulli, Luca; Zamparini, Manuel; Bossi, Paolo
Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer
2019-01-01 Mennini, F. S.; Marcellusi, A.; Fabiano, G.; Platini, F.; Bossi, P.
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus
2015-01-01 Schindler, A; Denaro, N; Russi, Eg; Pizzorni, N; Bossi, P; Merlotti, A; Bissetti, Ms; Numico, G; Gava, A; Orlandi, E; Caspiani, O; Buglione, M; Alterio, D; Bacigalupo, A; De Sanctis, V; Pavanato, G; Ripamonti, C; Merlano, Mc; Licitra, L; Sanguineti, G; Langendijk, Ja; Murphy, B
Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and Vomiting
2016-01-01 Bossi, P; Cortinovis, D; Rocca, Mc; Roila, F; Seminara, P; Fabi, A; Canova, S; Verri, E; Fatigoni, S; Iannace, A; Macchi, F; Ripamonti, C
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients
2011-01-01 Licitra, L; Perrone, F; Tamborini, E; Bertola, L; Ghirelli, C; Negri, T; Orsenigo, M; Filipazzi, P; Pastore, E; Pompilio, M; Bossi, P; Locati, Ld; Cantu', G; Scaramellini, G; Pilotti, S; Tagliabue, E
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients
2015-01-01 Osman, Aa; Neskey, Dm; Katsonis, P; Patel, Aa; Ward, Am; Hsu, Tk; Hicks, Sc; Mcdonald, To; Ow, Tj; Alves, Mo; Pickering, Cr; Skinner, Hd; Zhao, M; Sturgis, Em; Kies, Ms; El-Naggar, A; Perrone, F; Licitra, L; Bossi, P; Kimmel, M; Frederick, Mj; Lichtarge, O; Myers, Jn
Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE study
2020-01-01 Bossi, P.; Peris, K.; Calzavara-Pinton, P.; Queirolo, P.; Alfieri, S.; Palla, M.; Rossi, M. T.; Spagnolo, F.; Tambone, S.; Astolfi, C.; Ascierto, P. A.
Different inflammatory blood markers correlate with specific outcomes in incident HPV-negative head and neck squamous cell carcinoma: a retrospective cohort study
2022-01-01 Boscolo-Rizzo, P.; D'Alessandro, A.; Polesel, J.; Borsetto, D.; Tofanelli, M.; Deganello, A.; Tomasoni, M.; Nicolai, P.; Bossi, P.; Spinato, G.; Menegaldo, A.; Ciorba, A.; Pelucchi, S.; Bianchini, C.; Cazzador, D.; Ramaciotti, G.; Lupato, V.; Giacomarra, V.; Molteni, G.; Marchioni, D.; Fabbris, C.; Occhini, A.; Bertino, G.; Fussey, J.; Tirelli, G.
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma
2022-01-01 Lombardi, D.; Tomasoni, M.; Lorini, L.; Gurizzan, C.; Tomasini, D.; Ardighieri, L.; Battocchio, S.; Bozzola, A.; Mattavelli, D.; Paderno, A.; Zamparini, M.; Farina, D.; Ravanelli, M.; Maroldi, R.; Maddalo, M.; Magrini, S.; Berruti, A.; Deganello, A.; Nicolai, P.; Bossi, P.; Piazza, C.
THE IMPACT OF INDUCTION CHEMOTHERAPY ON CISPLATION DOSE INTENSITY DURING CHEMO-RADIOTHERAPY (CTRT) IN OROPHARYNGEAL SQUAMOUS CELL CANCER (OPC)
2012-01-01 Granata, R; Bossi, P; Orlandi, E; Locati, L; Bergamini, C; Resteghini, C; Ibba, T; Scaramellini, G; Fallai, C; Licitra, L
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1]
2003-01-01 Locati, L. D.; Quattrone, P.; Bossi, P.; Marchiano, A. V.; Cantu, G.; Licitra, L.
Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines
2019-01-01 Hong, C. H. L.; Gueiros, L. A.; Fulton, J. S.; Cheng, K. K. F.; Kandwal, A.; Galiti, D.; Fall-Dickson, J. M.; Johansen, J.; Ameringer, S.; Kataoka, T.; Weikel, D.; Eilers, J.; Ranna, V.; Vaddi, A.; Lalla, R. V.; Bossi, P.; Elad, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Differential impact of cisplatin dose intensity on human papillomavirus (HPV)-related (+) and HPV-unrelated (-) locoregionally advanced head and neck squamous cell carcinoma (LAHNSCC) | 1-gen-2015 | Spreafico, A; Huang, Sh; Xu, W; Granata, R; Liu, Cs; Waldron, Jn; Chen, E; Ringash, J; Bayley, A; Chan, Kk; Hope, Aj; Razak, Ara; Perez-Ordonez, B; Weinreb, I; Bossi, P; Orlandi, E; Licitra, Lf; O'Sullivan, B; Siu, Ll; Kim, Jhj | |
| Targeting the EGFR and immune pathways in squamous cell carcinoma of the head and neck (SCCHN): Forging a new alliance | 1-gen-2019 | Saba, N. F.; Chen, Z. G.; Haigentz, M.; Bossi, P.; Rinaldo, A.; Rodrigo, J. P.; Makitie, A. A.; Takes, R. P.; Strojan, P.; Vermorken, J. B.; Ferlito, A. | |
| Comment on 'Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base' | 1-gen-2015 | Bossi, P; Orlandi, E; Licitra, L | |
| A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck | 1-gen-2017 | Bossi, P.; Miceli, R.; Locati, L. D.; Ferrari, D.; Vecchio, S.; Moretti, G.; Denaro, N.; Caponigro, F.; Airoldi, M.; Moro, C.; Vaccher, E.; Sponghini, A.; Caldara, A.; Rinaldi, G.; Ferrau, F.; Nole, F.; Lo Vullo, S.; Tettamanzi, F.; Hollander, L.; Licitra, L. | |
| Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis | 1-gen-2021 | Milione, M.; Maisonneuve, P.; Grillo, F.; Mangogna, A.; Centonze, G.; Prinzi, N.; Pusceddu, S.; Garzone, G.; Cattaneo, L.; Busico, A.; Bossi, P.; Spaggiari, P.; Pellegrinelli, A.; Del Gobbo, A.; Ferrero, S.; Kankava, K.; Pruneri, G.; Rolli, L.; Roca, E.; Bercich, L.; Tironi, A.; Benvenuti, M. R.; Gallazzi, M. S.; Romano, R.; Berruti, A.; Pastorino, U.; Capella, C. | |
| A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact | 1-gen-2016 | Locati, Ld; Perrone, F; Cortelazzi, B; Bergamini, C; Bossi, P; Civelli, E; Morosi, C; Lo Vullo, S; Imbimbo, M; Quattrone, P; Dagrada, Gp; Granata, R; Resteghini, C; Mirabile, A; Alfieri, S; Orlandi, E; Mariani, L; Saibene, G; Pilotti, S; Licitra, L | |
| Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature | 1-gen-2019 | Bossi, P.; Alfieri, S.; Strojan, P.; Takes, R. P.; Lopez, F.; Makitie, A.; Saba, N. F.; Rodrigo, J. P.; Bradford, C.; Suarez, C.; Zafereo, M.; Forastiere, A. A.; Vermorken, J. B.; Quer, M.; Sanabria, A.; Simo, R.; de Bree, R.; Rinaldo, A.; Ferlito, A. | |
| Vitamin D supplementation and cancer mortality: Narrative review of observational studies and clinical trials | 1-gen-2021 | Gnagnarella, P.; Muzio, V.; Caini, S.; Raimondi, S.; Martinoli, C.; Chiocca, S.; Miccolo, C.; Bossi, P.; Cortinovis, D.; Chiaradonna, F.; Palorini, R.; Facciotti, F.; Bellerba, F.; Canova, S.; Gandini, S. | |
| Corrigendum to "Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma" [Eur J Canc 157 (2021) 250-258] | 1-gen-2022 | Baggi, Alice; Quaglino, Pietro; Rubatto, Marco; Depenni, Roberta; Guida, Michele; Ascierto, Paolo Antonio; Trojaniello, Claudia; Queirolo, Paola; Saponara, Maristella; Peris, Ketty; Spagnolo, Francesco; Bianchi, Luca; De Galitiis, Federica; Potenza, Maria Concetta; Proietti, Ilaria; Marconcini, Riccardo; Botticelli, Andrea; Barbieri, Vito; Licitra, Lisa; Alfieri, Salvatore; Ficorella, Corrado; Cortellini, Alessio; Fargnoli, Maria Concetta; Troiani, Teresa; Tondulli, Luca; Zamparini, Manuel; Bossi, Paolo | |
| Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer | 1-gen-2019 | Mennini, F. S.; Marcellusi, A.; Fabiano, G.; Platini, F.; Bossi, P. | |
| Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus | 1-gen-2015 | Schindler, A; Denaro, N; Russi, Eg; Pizzorni, N; Bossi, P; Merlotti, A; Bissetti, Ms; Numico, G; Gava, A; Orlandi, E; Caspiani, O; Buglione, M; Alterio, D; Bacigalupo, A; De Sanctis, V; Pavanato, G; Ripamonti, C; Merlano, Mc; Licitra, L; Sanguineti, G; Langendijk, Ja; Murphy, B | |
| Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and Vomiting | 1-gen-2016 | Bossi, P; Cortinovis, D; Rocca, Mc; Roila, F; Seminara, P; Fabi, A; Canova, S; Verri, E; Fatigoni, S; Iannace, A; Macchi, F; Ripamonti, C | |
| Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients | 1-gen-2011 | Licitra, L; Perrone, F; Tamborini, E; Bertola, L; Ghirelli, C; Negri, T; Orsenigo, M; Filipazzi, P; Pastore, E; Pompilio, M; Bossi, P; Locati, Ld; Cantu', G; Scaramellini, G; Pilotti, S; Tagliabue, E | |
| Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients | 1-gen-2015 | Osman, Aa; Neskey, Dm; Katsonis, P; Patel, Aa; Ward, Am; Hsu, Tk; Hicks, Sc; Mcdonald, To; Ow, Tj; Alves, Mo; Pickering, Cr; Skinner, Hd; Zhao, M; Sturgis, Em; Kies, Ms; El-Naggar, A; Perrone, F; Licitra, L; Bossi, P; Kimmel, M; Frederick, Mj; Lichtarge, O; Myers, Jn | |
| Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE study | 1-gen-2020 | Bossi, P.; Peris, K.; Calzavara-Pinton, P.; Queirolo, P.; Alfieri, S.; Palla, M.; Rossi, M. T.; Spagnolo, F.; Tambone, S.; Astolfi, C.; Ascierto, P. A. | |
| Different inflammatory blood markers correlate with specific outcomes in incident HPV-negative head and neck squamous cell carcinoma: a retrospective cohort study | 1-gen-2022 | Boscolo-Rizzo, P.; D'Alessandro, A.; Polesel, J.; Borsetto, D.; Tofanelli, M.; Deganello, A.; Tomasoni, M.; Nicolai, P.; Bossi, P.; Spinato, G.; Menegaldo, A.; Ciorba, A.; Pelucchi, S.; Bianchini, C.; Cazzador, D.; Ramaciotti, G.; Lupato, V.; Giacomarra, V.; Molteni, G.; Marchioni, D.; Fabbris, C.; Occhini, A.; Bertino, G.; Fussey, J.; Tirelli, G. | |
| Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma | 1-gen-2022 | Lombardi, D.; Tomasoni, M.; Lorini, L.; Gurizzan, C.; Tomasini, D.; Ardighieri, L.; Battocchio, S.; Bozzola, A.; Mattavelli, D.; Paderno, A.; Zamparini, M.; Farina, D.; Ravanelli, M.; Maroldi, R.; Maddalo, M.; Magrini, S.; Berruti, A.; Deganello, A.; Nicolai, P.; Bossi, P.; Piazza, C. | |
| THE IMPACT OF INDUCTION CHEMOTHERAPY ON CISPLATION DOSE INTENSITY DURING CHEMO-RADIOTHERAPY (CTRT) IN OROPHARYNGEAL SQUAMOUS CELL CANCER (OPC) | 1-gen-2012 | Granata, R; Bossi, P; Orlandi, E; Locati, L; Bergamini, C; Resteghini, C; Ibba, T; Scaramellini, G; Fallai, C; Licitra, L | |
| A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] | 1-gen-2003 | Locati, L. D.; Quattrone, P.; Bossi, P.; Marchiano, A. V.; Cantu, G.; Licitra, L. | |
| Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines | 1-gen-2019 | Hong, C. H. L.; Gueiros, L. A.; Fulton, J. S.; Cheng, K. K. F.; Kandwal, A.; Galiti, D.; Fall-Dickson, J. M.; Johansen, J.; Ameringer, S.; Kataoka, T.; Weikel, D.; Eilers, J.; Ranna, V.; Vaddi, A.; Lalla, R. V.; Bossi, P.; Elad, S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891